Personalised drugs

Health 24-11-2017

Athens brings its dispute with pharma industry to the EU Council

The next EU Health Council on 8 December will discuss the “lack of drug availability in Greece”, amid mounting tensions between the leftist government in Athens and the pharmaceutical companies.

Health 02-11-2017

Pharmaceutical company gives free access to drug after clash with Greek government

Following a clash with the Greek government over its decision to withdraw a cancer drug from the market, ROCHE, a Swiss multinational company, ultimately decided to make the drug available to patients for free.

Health 31-10-2017

Greek health minister fumes at pharmaceutical company after drug withdrawal

The Greek ministry of health reacted strongly to the decision of a pharmaceutical company to withdraw a drug from the market for “viability” reasons, saying it will not accept any blackmail.

Health 30-10-2017

Pharmaceutical company withdraws oncology drug from Greek market

A multinational pharmaceutical company has decided to withdraw an innovative oncology medicine from the Greek market, claiming that its price has fallen more than 50% because of the government’s regulatory interventions in the pharma area, EURACTIV.com has learnt.

Health 25-10-2017

Greek government on collision course with pharmaceutical companies over innovative drugs

Several pharmaceutical companies in Greece have threatened to stop supplying the market with innovative drugs and said they could even withdraw existing drugs as a result of an obligatory “discount” imposed by the Greek government and applied retroactively.

Health 12-10-2017

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.

Health 10-10-2017

Andriukaitis: Supporting drug innovation is ‘the only way’

Backing innovation in the pharmaceutical market and developing new evidence-based economic models is the only way forward for future healthcare, according to EU Commissioner for Health and Food Safety Vytenis Andriukaitis.

Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.

Clinical trials 03-05-2017

Allowing patients to choose could save billions

The Commission’s recent musings on the social dimension of Europe touches on common drug pricing among member states. But it misses out on solutions for faster access to medicine, Fred Roeder.

Health 07-04-2017

IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.

Health 06-04-2017

Europe’s biotechnology potential hindered by investment fears

In terms of pure biotechnology, Europe has embraced innovation. However, it cannot compete with the US yet because it cannot drive private investment in the field, as well as open up the market to new products, a pharmaceutical executive told EURACTIV.com in Lyon.

Health 15-03-2017

Commission sees biotech as ‘integral part’ of EU healthcare

Biotechnology-derived medicinal products are fully part of EU healthcare but there are still many unknowns which call for adequate controls, the European Commission told EURACTIV.